Completion of National Audit: Analysis of Prescription Drug Event Records for Nuedexta for Beneficiaries without a Medically Accepted Indication  

Relevant to:  All Medicare Advantage Organizations (MAOs) and Prescription Drug Plan Sponsors (PDPs) 

 The Centers for Medicare & Medicaid Services (CMS), in collaboration with the Plan Program Integrity Medicare Drug Integrity Contractor (PPI MEDIC), conducted a National Audit of Medicare Part D Payments for Nuedexta prescribed without a documented medically accepted indication (MAI) under the Medicare Part A, Part B, or Part C programs. 

See the full guidance for more information.